Home/Filings/4/0000905148-24-001495
4//SEC Filing

Peterson Katharine 4

Accession 0000905148-24-001495

CIK 0001781174other

Filed

May 15, 8:00 PM ET

Accepted

May 16, 7:05 PM ET

Size

4.4 KB

Accession

0000905148-24-001495

Insider Transaction Report

Form 4
Period: 2024-05-14
Peterson Katharine
Chief Accounting Officer
Transactions
  • Tax Payment

    Common Stock

    2024-05-14$8.36/sh99$8284,733 total
Footnotes (1)
  • [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Documents

1 file

Issuer

Acrivon Therapeutics, Inc.

CIK 0001781174

Entity typeother

Related Parties

1
  • filerCIK 0002022214

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 7:05 PM ET
Size
4.4 KB